Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Harris

Showing results (471-480 of 484) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancerG E Trivers, V M De Benedetti, H L Cawley, et al.
Human Pathology|April 4, 2000
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesionsF B Galateau-Salle, R E Luna, K Horiba, et al.
Oncogene|May 3, 2011
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancerR K Gill, S-H Yang, D Meerzaman, et al.
Pharmacogenetics|January 26, 1999
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancerR M Przygodzki, W P Bennett, D G Guinee, et al.
Molecular Carcinogenesis|June 12, 1999
Thirteenth Aspen Cancer Conference: workshop on mechanisms of toxicity and carcinogenesisS Nesnow, W Cavanee, T M Gilmer, et al.
Journal of the National Cancer Institute|November 8, 2001
Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinomaA J Marrogi, M A Khan, H E van Gijssel, et al.
British Journal of Cancer|September 5, 2013
Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)A C Pesatori, M Carugno, D Consonni, et al.
Human Pathology|January 28, 1998
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patientsM V Fleming, D G Guinee, W S Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseasesS P Hussain, K Raja, P A Amstad, et al.
Cancer Research|July 17, 2001
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinomaS A Nicholson, N T Okby, M A Khan, et al.
Pageof 49

Showing results (471-480 of 484) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancerG E Trivers, V M De Benedetti, H L Cawley, et al.
Human Pathology|April 4, 2000
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesionsF B Galateau-Salle, R E Luna, K Horiba, et al.
Oncogene|May 3, 2011
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancerR K Gill, S-H Yang, D Meerzaman, et al.
Pharmacogenetics|January 26, 1999
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancerR M Przygodzki, W P Bennett, D G Guinee, et al.
Molecular Carcinogenesis|June 12, 1999
Thirteenth Aspen Cancer Conference: workshop on mechanisms of toxicity and carcinogenesisS Nesnow, W Cavanee, T M Gilmer, et al.
Journal of the National Cancer Institute|November 8, 2001
Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinomaA J Marrogi, M A Khan, H E van Gijssel, et al.
British Journal of Cancer|September 5, 2013
Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)A C Pesatori, M Carugno, D Consonni, et al.
Human Pathology|January 28, 1998
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patientsM V Fleming, D G Guinee, W S Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseasesS P Hussain, K Raja, P A Amstad, et al.
Cancer Research|July 17, 2001
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinomaS A Nicholson, N T Okby, M A Khan, et al.
Pageof 49